Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

Huidi Liu1,2,3,4,5, Zheng Zeng1,2,3, Mitra Afsharpad6

  • 1Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy, Harbin Medical University, Harbin, China.

Frontiers in Oncology
|February 22, 2020
PubMed

Insights

Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) promotes ovarian clear cell carcinoma (OCCC) progression. Targeting IGF2BP3 inhibits OCCC cell proliferation, migration, invasion, and tumor growth, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian Clear Cell Carcinoma (OCCC) has a poor prognosis due to limited effective therapies.
  • Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) is an RNA-binding protein influencing gene expression post-transcriptionally.

Purpose of the Study:

  • To investigate the role of IGF2BP3 in OCCC progression.
  • To determine the association between IGF2BP3 expression and clinicopathological parameters in OCCC.
  • To evaluate IGF2BP3 as a potential therapeutic target for OCCC.

Main Methods:

  • Analysis of 328 OCCC samples from the AOVT and COEUR cohorts.
  • Assessment of IGF2BP3 expression and its correlation with clinicopathological parameters and survival.
  • In vitro and in vivo knockdown experiments using IGF2BP3-overexpressing OCCC cell lines (ES2, OVMANA) with siRNAs.
  • Evaluation of cell proliferation, viability, migration, invasion, and apoptosis.
  • Measurement of metastasis-related proteins MMP2 and MMP9.

Main Results:

  • Positive IGF2BP3 expression was more frequent in Stage III OCCC and associated with unfavorable overall survival.
  • IGF2BP3 mRNA expression was significantly increased in OCCC cell lines compared to normal ovarian surface epithelium.
  • IGF2BP3 knockdown inhibited OCCC cell proliferation, viability, migration, and invasion, and enhanced apoptosis.
  • In vivo tumor growth was significantly reduced following IGF2BP3 siRNA treatment.
  • Down-regulation of MMP2 and MMP9 proteins was observed after IGF2BP3 knockdown.

Conclusions:

  • IGF2BP3 expression is a potential prognostic biomarker for OCCC.
  • IGF2BP3 plays a significant role in OCCC progression by affecting key cellular functions.
  • IGF2BP3 represents a potential therapeutic target for OCCC intervention strategies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K